The Hepatitis B Vaccine and Celiac Disease: More Lights Than Shadows?

authors:

avatar Giovanna Vitaliti 1 , * , avatar Angela Lanzafame 1 , avatar Mario La Rosa 1 , avatar Salvatore Leonardi 1

Department of Pediatrics, University of Catania, Catania, Italy
Hepatitis Monthly: Vol.13, issue 1; e7878
published online: January 20, 2013
article type: Letter
received: August 23, 2012
accepted: September 24, 2012
DOI: https://doi.org/10.5812/hepatmon.7878

how to cite: Vitaliti G, Lanzafame A, La Rosa M, Leonardi S. The Hepatitis B Vaccine and Celiac Disease: More Lights Than Shadows?. Hepat Mon. 2013;13(1):e7878. https://doi.org/10.5812/hepatmon.7878.

References

  • 1.

    Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol. 2003;98(10):2289-92. [PubMed ID: 14572581]. https://doi.org/10.1111/j.1572-0241.2003.07701.x.

  • 2.

    Nemes E, Lefler E, Szegedi L, Kapitany A, Kovacs JB, Balogh M, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics. 2008;121(6):e1570-6.

  • 3.

    Leonardi S, La Rosa M. Are hepatitis B virus and celiac disease linked? Hepat Mon. 2010;10(3):173-5. [PubMed ID: 22308135].

  • 4.

    Leonardi S, Del Giudice MM, Spicuzza L, Spina M, La Rosa M. Hepatitis B vaccine administered by intradermal route in patients with celiac disease unresponsive to the intramuscular vaccination schedule: a pilot study. Am J Gastroenterol. 2010;105(9):2117-9. [PubMed ID: 20818367]. https://doi.org/10.1038/ajg.2010.195.

  • 5.

    Dubois B, Bridon JM, Fayette J, Barthelemy C, Banchereau J, Caux C, et al. Dendritic cells directly modulate B cell growth and differentiation. J Leukoc Biol. 1999;66(2):224-30. [PubMed ID: 10449158].

  • 6.

    Leonardi S, Pratico AD, Lionetti E, Spina M, Vitaliti G, Rosa ML. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol. 2012;18(40):5729-33. [PubMed ID: 23155313]. https://doi.org/10.3748/wjg.v18.i40.5729.

  • 7.

    Sangfelt P, Uhnoo I, Reichard O, Weiland O. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting. Scand J Gastroenterol. 2008;43(4):465-72. [PubMed ID: 18365912]. https://doi.org/10.1080/00365520701733806.

  • 8.

    Leonardi S, Leggio T, Sciacca A, Di Gregorio F, Musumeci S. Intradermal hepatitis B vaccination in thalassaemia. Arch Dis Child. 1990;65(5):527-9. [PubMed ID: 2141464]. https://doi.org/10.1136/adc.65.5.527.

  • 9.

    Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005;366(9494):1379-84. https://doi.org/10.1016/S0140-6736(05)67568-X.